IFNG and neoplasm: T-cell reactivity against autologous tumor tissue lysates as determined in IFNγ  ELISPOT was found to be weakly increased after therapy, and no correlation could be established between the breadth of the immune response and the clinical course as measured by analysis of PSA serum levels [85, 102].